Effects of low temperature and high salt on the activity of the novel carbapenem PZ-601 (SMP-601) against methicillin-resistant Staphylococcus aureus

Journal of Antimicrobial Chemotherapy

Volumn 63, Issue 2, 2009, Pages 411-413

  Livermore, David M ^a   Warner, Marina ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

mecA; MRSA; Staphylococci

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFTAROLINE; CEFTOBIPROLE; IMIPENEM; NEW DRUG; PZ 601; SMP 601; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATION; DRUG STRUCTURE; EPIDEMIC; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SALT LOADING; TEMPERATURE SENSITIVITY;

ANTI-BACTERIAL AGENTS; CARBAPENEMS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; SALTS; TEMPERATURE;

EID: 58849142985     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn498     Document Type: Letter

References (8)

1. Pace J, Stevens T, Hamrick J et al. PZ-601 susceptibility of Gram-positive pathogens causative for skin, systemic, and respiratory infections. In: Abstracts of the Forty-sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 2006. Abstract F1-230, p. 199. American Society for Microbiology, Washington, DC, USA.
2. Brown DF, Edwards DI, Hawkey PM et al. Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). J Antimicrob Chemother 2005; 56: 1000-18.
3. Livermore DM. Can β-lactams be re-engineered to beat MRSA? Clin Microbiol Infect 2006; 12 Suppl 2: 11-6.
4. Mushtaq S, Warner M, Ge Y et al. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes. J Antimicrob Chemother 2007; 60: 300-11.
5. Ling JM, Lam AW, Cheng AF et al. Activity of β-lactam antibiotics in an animal model against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1993; 32: 919-20.
6. Johnson AP, Pearson A, Duckworth G. Surveillance and epidemiology of MRSA bacteraemia in the UK. J Antimicrob Chemother 2005; 56: 455-62.
7. Enright MC, Day NP, Davies CE et al. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000; 38: 1008-15.
8. Stefani S, Mezzatesta M, Trovato G et al. Antibacterial activity of PZ-601 against well-characterized and recent clinical isolates of methicillin-resistant Staphylococcus aureus. In: Abstracts of the Forty-sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 2006. Abstract F1-231, p. 199. American Society for Microbiology, Washington, DC, USA.